Thursday, June 24, 2010 10:16:06 PM
Posted By Dr. Mercola
June 24 2010
Scientists who were responsible for World Health Organization (WHO) advice on stockpiling of pandemic flu drugs had financial ties with companies which stood to profit, according to an investigation. WHO made no mention of the links.
A spokesman for WHO said the drug industry did not influence its decisions on swine flu.
However, in case there was any doubt about it, the emergency committee that advises WHO has announced today that swine flu is still a pandemic -- even as medical authorities are saying that the virus is past its peak.
BBC News reports:
"Guidelines recommending governments stockpile antiviral drugs were issued by WHO in 2004. The advice prompted many countries around the world into buying up large stocks of Tamiflu, made by Roche, and Relenza manufactured by GlaxoSmithKline.
A year after the swine flu pandemic was declared, stocks are left unused in warehouses and governments are attempting to unpick contracts."
BBC News June 4, 2010
ABC News June 3, 2010
British Medical Journal June 3, 2010; 340
ABC News June 5, 2010
Washington Post June 4, 2010
Dr. Mercola's Comments:Fortunately, and largely as a result of our correct predictions and advice, over 70% of the U.S. population refused to take the vaccine. We were also able to prevent the use of squalene in the vaccine for those that did receive it and, most importantly, we were able to help prevent mandatory vaccination.
A major victory by any measure in that millions of dangerous complications and side effects were avoided by implementing the strategy we advocated.
It was just a little over a year ago that the World Health Organization (WHO) raised its swine flu pandemic alert from a 5 to a 6, a move that sent governments around the world scrambling to stockpile antiviral flu drugs and vaccines, while causing panic in countries around the world.
By this time, the swine flu virus was already showing itself to have mild symptoms, quick recovery time, and low incidence of death among the vast majority of H1N1 patients throughout the world.
Yet the drug companies needed to begin shipping out their profitable new H1N1 vaccine and antiviral drugs across the world was for the swine flu to be kicked up one notch, from a phase 5 to a phase 6 pandemic … and that is exactly what they got.
If you didn't find this suspicious before, I suspect you'll find it hard to swallow now in light of the latest information that reveals some of the very same "scientists," and I use that term lightly, who advised WHO on their decisions were paid consultants with the drug industry.
Drug Company Insiders Disguised as Scientists Advised WHO
A joint investigation by the BMJ and the Bureau of Investigative Journalism found that three key scientists who advised WHO on the stockpiling of pandemic flu drugs had been paid by drug companies Roche and GlaxoSmithKline for lectures and consulting work, as well as were involved in research for the companies.
The obvious conflicts of interest were not publicly declared by WHO, despite the fact that conflict of interest forms had apparently been collected by the organization. The findings shed even more doubt into whose interest WHO was looking out for when it declared swine flu a pandemic last year.
Max nested elements reachedMax nested elements reached
Tuesday, June 22, 2010 8:46:59 PM
More cases are being reported from Bihar and Uttar Pradesh despite increased doses
IT’S NOT JUST the proposed-pentavalent vaccine that is causing problems. India’s Pulse Polio Immunisation programme is apparently not showing the results it was expected to. The worst states for polio in India, Uttar Pradesh and Bihar are now reporting more cases of Acute Flaccid Paralysis (AFP), even from last year, even though the doses have been increased.
The AFP rate is the number of persons paralysed per 100,000 population. Ordinarily, it is expected to be one or two per 100,000. But, the official figures of the National Polio Surveillance Project (NPSP), a joint effort of the union government and the WHO, show that the number of AFP cases by the first week of June 2009 were 4,280 in Bihar. This year, the figure has gone up to 5,190, which is a 21.26 percent increase. In Uttar Pradesh, the AFP cases have gone up from 5,286 in June 2009 to 6,824 in June this year. This represents a 22.54 percent increase.
Almost all cases of AFP are seen as polio. “When we refer to AFP, we take it polio although not all AFP cases are caused by the polio virus. But a majority would be,” says Dr Sanjeev Singh, an advisor to many hospitals in Delhi. Singh says he can barely recall two cases of non-polio AFP over several years of work.
There is a 20 percent increase in the cases of AFP from last year, but the government says very few are confirmed as polio
However, the NPSP says only six of the 5,190 AFP cases from Bihar are confirmed polio cases so far this year. It also says it has discarded 4,266 cases as not polio and that 918 cases are pending. Likewise, in Uttar Pradesh the NPSP is confirming only 10 cases of AFP as polio so far adding it has discarded 5,362 cases as not polio and 1,450 cases are pending.
Another reason given for the increase in polio cases even after a massive Pulse Polio Immunisation programme is that there is better surveillance now, people are more aware, and they are therefore reporting more cases now. If that were so, there is all the possibility of far more polio cases being discovered. This, in turn, raises doubts over the efficacy of the polio vaccine.
In 2007, TEHELKA reported that a new polio vaccine was introduced without informing the public and the the AFP rate in Uttar Pradesh rose from 3,789 in 2004 to 10,055 in 2005, when six doses of oral polio vaccine were given, and to 11,538 in 2006 when a further nine doses were administered.
In 2006, the AFP rate in Uttar Pradesh was 16.87 per 100,000. Today, it is 22. In Bihar it is 32. So, is the repeated vaccination in these states, which are receiving more doses, responsible? AFP is no mild disease. About half the cases are permanently paralysed, says an analysis in the journal Indian Pediatrics. It appears that the polio vaccine is another example of the government ceding to international agencies, who are pushing for more doses.
From Tehelka Magazine, Vol 7, Issue 24, Dated June 19, 2010
Tehelka.com is a part of Anant Media Pvt. Ltd. © 2000 - 2010 All rights reserved
Friday, January 8, 2010 12:39:18 PM
Vaccines are available, needed
By BLAKE THORNE
The Holland Sentinel
Posted Jan 08, 2010 @ 05:49 AM
SAY IT AGAIN! SWINE FLU PANDEMIC IS A HOAX!
Holland, MI — Now is not the time to forget about H1N1.
Though reported cases of the virus have dropped in recent weeks, those not already vaccinated should get vaccines, health officials said Thursday.
“The H1N1 virus is still circulating and it is still causing disease, hospitalizations and deaths,” said Dr. Anne Schuchat, director of the Centers for Disease Control’s National Center for Immunization and Respiratory Diseases, in a press conference Thursday. “Many people are still susceptible to this virus and would benefit from vaccinations.”
Nationwide, 136 million doses of H1N1 vaccine are available.
“We want to avoid complacency,” Schuchat said.
H1N1 vaccines have been more readily available than in October and November, when the pandemic seemed in full force.
Initially, vaccine supplies were limited and health officials restricted doses to certain high-risk populations.
In December, those restrictions were lifted, and vaccines became readily available through pharmacies and physicians. The Ottawa County Health Department has stopped hosting vaccine clinics because the vaccine is so accessible.
“We are still encouraging people to get vaccinated,” said Shannon Felgner, health department spokeswoman. “There’s certainly a strong possibility that H1N1 will be rearing its head again.”
But as reports of H1N1 have dropped, so has the demand for vaccines. At Holland Hospital, requests for vaccine information — along with incoming patients showing flu-like symptoms — have declined steadily over the past six to eight weeks, said Tim Breed, hospital spokesman.
“There aren’t as many people that are getting it (the vaccine) as should be,” said Jim Bussis, pharmacist at Paul’s Pharmacy in Holland.
The cost for the vaccine is usually around $15 to $20, local pharmacists reported.
“I am concerned that people may become complacent, that people may think this is all over,” Schuchat said. “We have the chance for people to protect themselves.”
Copyright © 2006–2010 GateHouse Media, Inc. Some Rights Reserved.
Thursday, January 7, 2010 8:39:27 PM
Jan 7, 2010 - 13:01Health officials say the swine flu pandemic is likely to be over in Switzerland within the next four weeks.
Patrick Mathys of the Federal Health Office said up to 1.5 million had been infected with the A/H1N1 virus in the country so far but in most cases the illness had been mild.
At least 15 people have died from complications of swine flu in Switzerland. Most of the victims were old or suffered from a chronic disease.
About 480 people were admitted to hospital with flu symptoms and nearly 90 of them were treated in intensive care, Mathys said.
Experts on Thursday also point out that a regular seasonal flu virus could still hit Europe in the next few weeks.
The government had bought 13 million doses of vaccine to contain a possible swine flu pandemic.
However, it is estimated that only one in five of the 7.7 million Swiss residents took advantage of the free vaccinations.
There was criticism about the efficiency of the immunisation programme and logistical difficulties.
swissinfo.ch with agencies